Definitive Healthcare Launches Monocl Conferences to Improve Conference Planning and Participation for Biopharma and Medtech Organizations
Definitive Healthcare Corp. (DH): Revolutionizing Healthcare Decisions With AI-Driven Insights
Definitive Healthcare Launches Predictive Analytics Solution That Empowers Healthcare Organizations to Prepare and Plan for Future Market Conditions
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
Implied Volatility Surging for Definitive Healthcare (DH) Stock Options
This Dell Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
BTIG Initiates Definitive Healthcare(DH.US) With Buy Rating, Announces Target Price $7
BTIG analyst David Larsen initiates coverage on $Definitive Healthcare(DH.US)$ with a buy rating, and sets the target price at $7.According to TipRanks data, the analyst has a success rate of 29.8%
Express News | Definitive Healthcare Corp : Btig Initiates Coverage With Buy Rating; Price Target $7
Definitive Healthcare Launches Powerful Consumer Analytics and Activation Solution to More Industries With Population Intelligence Expansion
Several Reasons Led Conestoga Capital Advisors to Sell Definitive Healthcare Corp. (DH)
Deutsche Bank Maintains Hold on Definitive Healthcare, Lowers Price Target to $5
Analysts Have Been Trimming Their Definitive Healthcare Corp. (NASDAQ:DH) Price Target After Its Latest Report
Express News | Definitive Healthcare Corp : Jefferies Cuts Target Price to $8 From $10
Definitive Healthcare Price Target Cut to $4.00/Share From $6.00 by Barclays
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Baird Maintains Neutral on Definitive Healthcare, Lowers Price Target to $5
Definitive Healthcare Second Quarter 2024 Earnings: EPS Misses Expectations
Barclays Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
Barclays analyst Saket Kalia maintains $Definitive Healthcare(DH.US)$ with a hold rating, and adjusts the target price from $6 to $4.According to TipRanks data, the analyst has a success rate of 56.3%
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Definitive Healthcare Corp (DH) and Bicycle Therapeutics (BCYC)
Goldman Sachs Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
Goldman Sachs analyst Kash Rangan maintains $Definitive Healthcare(DH.US)$ with a hold rating, and adjusts the target price from $10 to $4.According to TipRanks data, the analyst has a success rate